These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21321582)

  • 1. Survey of US public attitudes toward pharmacogenetic testing.
    Haga SB; O'Daniel JM; Tindall GM; Lipkus IR; Agans R
    Pharmacogenomics J; 2012 Jun; 12(3):197-204. PubMed ID: 21321582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing uptake of pharmacogenetic testing in a diverse patient population.
    O'Daniel J; Lucas J; Deverka P; Ermentrout D; Silvey G; Lobach DF; Haga SB
    Public Health Genomics; 2010; 13(1):48-54. PubMed ID: 19407441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions.
    Haga SB; O'Daniel JM; Tindall GM; Lipkus IR; Agans R
    Genet Med; 2011 Aug; 13(8):723-8. PubMed ID: 21633294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testing.
    Haga SB; O'Daniel JM; Tindall GM; Mills R; Lipkus IM; Agans R
    Clin Genet; 2012 Aug; 82(2):115-20. PubMed ID: 22283474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes toward pharmacogenetics in patients undergoing
    Lee G; Varughese LA; Conway L; Stojinski C; Ashokkumar S; Monono K; Matthai W; Kolansky DM; Giri J; Tuteja S
    Per Med; 2022 Mar; 19(2):93-101. PubMed ID: 34984913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perception of personalized medicine, pharmacogenomics, and genetic testing among undergraduates in Hong Kong.
    Cheung NYC; Fung JLF; Ng YNC; Wong WHS; Chung CCY; Mak CCY; Chung BHY
    Hum Genomics; 2021 Aug; 15(1):54. PubMed ID: 34407885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public perspectives about pharmacogenetic testing and managing ancillary findings.
    Haga SB; Tindall G; O'Daniel JM
    Genet Test Mol Biomarkers; 2012 Mar; 16(3):193-7. PubMed ID: 22047505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Child and adolescent psychiatrists' use, attitudes, and understanding of genetic testing and pharmacogenetics in clinical practice.
    Soda T; Merner AR; Small BJ; Torgerson LN; Muñoz K; Austin J; Storch EA; Pereira S; Lázaro-Muñoz G
    Psychiatry Res; 2023 Jul; 325():115246. PubMed ID: 37172398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public perceptions of pharmacogenetics.
    Zhang SC; Bruce C; Hayden M; Rieder MJ
    Pediatrics; 2014 May; 133(5):e1258-67. PubMed ID: 24777223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary care physicians' knowledge of and experience with pharmacogenetic testing.
    Haga SB; Burke W; Ginsburg GS; Mills R; Agans R
    Clin Genet; 2012 Oct; 82(4):388-94. PubMed ID: 22698141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Previous Genetic Counseling and Objective Numeracy on Accurate Interpretation of a Pharmacogenetics Test Report.
    Drelles K; Pilarski R; Manickam K; Shoben AB; Toland AE
    Public Health Genomics; 2021; 24(1-2):26-32. PubMed ID: 33445171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consideration of patient preferences and challenges in storage and access of pharmacogenetic test results.
    Haga SB; Kawamoto K; Agans R; Ginsburg GS
    Genet Med; 2011 Oct; 13(10):887-90. PubMed ID: 21673581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner-City Population.
    Lee YM; Manzoor BS; Cavallari LH; Nutescu EA
    Pharmacotherapy; 2018 Feb; 38(2):205-216. PubMed ID: 29286540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey on awareness, knowledge and preferences toward genetic testing among the United States general public.
    Fahim SM; Westrick SC; Qian J; Ngorsuraches S; Watts Alexander CS; Lloyd KB; Hohmann NS
    Per Med; 2024; 21(2):117-129. PubMed ID: 38380527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient perspectives following pharmacogenomics results disclosure in an integrated health system.
    Lemke AA; Hulick PJ; Wake DT; Wang C; Sereika AW; Yu KD; Glaser NS; Dunnenberger HM
    Pharmacogenomics; 2018 Mar; 19(4):321-331. PubMed ID: 29469671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comfort with Pharmacogenetic Testing Amongst Pediatric Oncology Providers and Their Patients.
    Mowbray C; Turner J; Gai J; Jacobs S
    J Pediatr Hematol Oncol Nurs; 2022; 39(3):168-177. PubMed ID: 35467433
    [No Abstract]   [Full Text] [Related]  

  • 17. Consumers' views of pharmacogenetics--A qualitative study.
    Haddy CA; Ward HM; Angley MT; McKinnon RA
    Res Social Adm Pharm; 2010 Sep; 6(3):221-31. PubMed ID: 20813335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public attitudes toward health information exchange: perceived benefits and concerns.
    Dimitropoulos L; Patel V; Scheffler SA; Posnack S
    Am J Manag Care; 2011 Dec; 17(12 Spec No.):SP111-6. PubMed ID: 22216769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive perception of pharmacogenetic testing for psychotropic medications.
    Lanktree MB; Zai G; Vanderbeek LE; Giuffra DE; Smithson DS; Kipp LB; Dalseg TR; Speechley M; Kennedy JL
    Hum Psychopharmacol; 2014 May; 29(3):287-91. PubMed ID: 24604560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public interest in genetic testing for susceptibility to heart disease and cancer: a population-based survey in the UK.
    Sanderson SC; Wardle J; Jarvis MJ; Humphries SE
    Prev Med; 2004 Sep; 39(3):458-64. PubMed ID: 15313084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.